Institut Curie

This study tested a new drug called PLX038 in 14 people with advanced triple-negative breast cancer that had already been treated. The goal was to see if the drug could shrink tumors. The trial was stopped early, so results are limited.

This study tested a drug called PF-05212384 in people with specific types of leukemia or related blood cancers that came back or didn't respond to treatment. The trial aimed to see if the drug could shrink or control the cancer. Only 10 people took part before the study was stopp…

This early-phase study tested two experimental drugs, tuvusertib and PLX038, in people with advanced solid tumors that could not be cured. The goal was to find the safest dose and see if the combination could shrink tumors. Only 10 people took part before the trial was stopped ea…

This study looked at whether special hemostatic dressings can reduce bleeding when changing bandages on malignant wounds (cancer sores) in adults. Only 4 patients were enrolled before the study ended early. The goal was to find a dressing that causes less bleeding and pain during…

This study aimed to see if DNA from cervical cancer tumors can be found in the blood, which might help doctors detect early signs of cancer spread. Researchers planned to enroll 26 patients with cervical cancer before treatment. The study was terminated early, so results are limi…